A Study of LY3556050 in Healthy Participants
Condition:   Healthy Interventions:   Drug: LY3556050;   Drug: Placebo;   Drug: Iohexol;   Drug: Metformin Sponsor:   Eli Lilly and Company Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 7, 2019 Category: Research Source Type: clinical trials

Mechanisms Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 2
Condition:   Heart Failure Interventions:   Drug: LCZ 696;   Drug: Icatibant;   Drug: placebo;   Drug: Para-aminohippurate;   Drug: Iohexol Sponsor:   Vanderbilt University Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 2, 2019 Category: Research Source Type: clinical trials

Control of Renal Oxygen Consumption, Mitochondrial Dysfunction, and Insulin Resistance
Conditions:   Diabetic Kidney Disease;   Type 1 Diabetes;   Diabetes;   Diabetes Mellitus;   Diabetes Complications;   Diabetic Nephropathies;   Type1diabetes;   Diabetes, Autoimmune;   Autoimmune Diabetes;   Juvenile Diabetes;   Type 1 Diabetes Mellitus Interventions:   Drug: Aminohippurate Sodium Inj 20%;   Drug: Iohexol Inj 300 milligrams/milliliter (mg/ml);   Radiation: PET/CT Scan Sponsors:   University of Colorado Denver School of Medicine Barbara Da...
Source: ClinicalTrials.gov - August 30, 2019 Category: Research Source Type: clinical trials

An Ascending Dose Study of BMS-986259 to Study Safety in Healthy Participants
Condition:   Healthy Participants Interventions:   Drug: BMS-986259;   Other: Placebo;   Diagnostic Test: P-Aminohippurate;   Diagnostic Test: Iohexol Sponsor:   Bristol-Myers Squibb Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 4, 2019 Category: Research Source Type: clinical trials